Even though numerous studies have shown that ACPA characterizes patients with a poor prognosis in terms of joint injury and inflammation [3,4], many authors have reported that the hematological and biochemical markers are associated with RA disease activity [5-9]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.